They're cashed up with about $3m on hand which is a big plus in the current economic environment - pretty tough times ahead for any business seeking a loan facility or capital raising.
Current outgoings are about $1m a year, and government R&D rebate also about $1m a year (if it continues), so that $3m should remain on hand for emergencies or a rainy day.
I don't think Covid 19 should greatly affect the progress of this business in the medium term, but it is and will certainly affect the share price.
- Forums
- ASX - By Stock
- CP1
- COVID-19
COVID-19, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)